P06494
Gene name |
Erbb2 (Neu) |
Protein name |
Receptor tyrosine-protein kinase erbB-2 |
Names |
EC 2.7.10.1 , Epidermal growth factor receptor-related protein , Proto-oncogene Neu , Proto-oncogene c-ErbB-2 , p185erbB2 , p185neu , CD antigen CD340 |
Species |
Rattus norvegicus (Rat) |
KEGG Pathway |
|
EC number |
2.7.10.1: Protein-tyrosine kinases |
Protein Class |
|

Descriptions
Autoinhibitory domains (AIDs)
Target domain |
172-314 (Domain II) |
Relief mechanism |
Partner binding, PTM |
Assay |
|
Accessory elements
864-889 (Activation loop from InterPro)
Target domain |
722-989 (Protein kinase domain) |
Relief mechanism |
|
Assay |
|
References
- Zhang X et al. (2006) "An allosteric mechanism for activation of the kinase domain of epidermal growth factor receptor", Cell, 125, 1137-49
- Ferguson KM et al. (2003) "EGF activates its receptor by removing interactions that autoinhibit ectodomain dimerization", Molecular cell, 11, 507-17
- Whitson KB et al. (2005) "Functional effects of glycosylation at Asn-579 of the epidermal growth factor receptor", Biochemistry, 44, 14920-31
- Contessa JN et al. (2008) "Inhibition of N-linked glycosylation disrupts receptor tyrosine kinase signaling in tumor cells", Cancer research, 68, 3803-9
- Huang X et al. (2009) "Structural insights into the inhibited states of the Mer receptor tyrosine kinase", Journal of structural biology, 165, 88-96
- Kovacs E et al. (2015) "Analysis of the Role of the C-Terminal Tail in the Regulation of the Epidermal Growth Factor Receptor", Molecular and cellular biology, 35, 3083-102
Autoinhibited structure

Activated structure

3 structures for P06494
Entry ID | Method | Resolution | Chain | Position | Source |
---|---|---|---|---|---|
1IIJ | NMR | - | A | 647-681 | PDB |
1N8Y | X-ray | 240 A | C | 23-631 | PDB |
AF-P06494-F1 | Predicted | AlphaFoldDB |
1 variants for P06494
Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
---|---|---|---|---|---|
661 | V>E | oncogenic NEU [UniProt] | No |
No associated diseases with P06494
13 regional properties for P06494
Type | Name | Position | InterPro Accession |
---|---|---|---|
domain | Receptor L-domain | 52 - 172 | IPR000494-1 |
domain | Receptor L-domain | 367 - 485 | IPR000494-2 |
domain | Protein kinase domain | 722 - 989 | IPR000719 |
domain | Serine-threonine/tyrosine-protein kinase, catalytic domain | 724 - 977 | IPR001245 |
domain | Furin-like cysteine-rich domain | 191 - 344 | IPR006211 |
repeat | Furin-like repeat | 190 - 231 | IPR006212-1 |
repeat | Furin-like repeat | 233 - 281 | IPR006212-2 |
repeat | Furin-like repeat | 503 - 609 | IPR006212-3 |
active_site | Tyrosine-protein kinase, active site | 843 - 855 | IPR008266 |
binding_site | Protein kinase, ATP binding site | 728 - 755 | IPR017441 |
domain | Tyrosine-protein kinase, catalytic domain | 722 - 978 | IPR020635 |
domain | Growth factor receptor domain 4 | 512 - 644 | IPR032778 |
domain | Epidermal growth factor receptor-like, transmembrane-juxtamembrane segment | 656 - 690 | IPR049328 |
Functions
Description | ||
---|---|---|
EC Number | 2.7.10.1 | Protein-tyrosine kinases |
Subcellular Localization |
|
|
PANTHER Family | ||
PANTHER Subfamily | ||
PANTHER Protein Class | ||
PANTHER Pathway Category | No pathway information available |
20 GO annotations of cellular component
Name | Definition |
---|---|
apical plasma membrane | The region of the plasma membrane located at the apical end of the cell. |
basal plasma membrane | The region of the plasma membrane located at the basal end of the cell. Often used in reference to animal polarized epithelial membranes, where the basal membrane is the part attached to the extracellular matrix, or in plant cells, where the basal membrane is defined with respect to the zygotic axis. |
basolateral plasma membrane | The region of the plasma membrane that includes the basal end and sides of the cell. Often used in reference to animal polarized epithelial membranes, where the basal membrane is the part attached to the extracellular matrix, or in plant cells, where the basal membrane is defined with respect to the zygotic axis. |
cytoplasm | The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures. |
cytoplasmic vesicle | A vesicle found in the cytoplasm of a cell. |
early endosome | A membrane-bounded organelle that receives incoming material from primary endocytic vesicles that have been generated by clathrin-dependent and clathrin-independent endocytosis; vesicles fuse with the early endosome to deliver cargo for sorting into recycling or degradation pathways. |
endosome membrane | The lipid bilayer surrounding an endosome. |
ERBB3:ERBB2 complex | A heterodimeric complex between the tyrosine kinase receptor ERBB2 and a ligand-activated receptor ERBB3. ERBB2, which does not bind any known ligand, is activated through formation of a heterodimer with another ligand-activated ERBB family member such as ERBB3. |
lateral loop | Non-compact myelin located adjacent to the nodes of Ranvier in a myelin segment. These non-compact regions include cytoplasm from the cell responsible for synthesizing the myelin. Lateral loops are found in the paranodal region adjacent to the nodes of Ranvier, while Schmidt-Lantermann clefts are analogous structures found within the compact myelin internode. |
microvillus | Thin cylindrical membrane-covered projections on the surface of an animal cell containing a core bundle of actin filaments. Present in especially large numbers on the absorptive surface of intestinal cells. |
myelin sheath | An electrically insulating fatty layer that surrounds the axons of many neurons. It is an outgrowth of glial cells |
neuromuscular junction | The junction between the axon of a motor neuron and a muscle fiber. In response to the arrival of action potentials, the presynaptic button releases molecules of neurotransmitters into the synaptic cleft. These diffuse across the cleft and transmit the signal to the postsynaptic membrane of the muscle fiber, leading to a change in post-synaptic potential. |
nucleus | A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent. |
perinuclear region of cytoplasm | Cytoplasm situated near, or occurring around, the nucleus. |
plasma membrane | The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. |
postsynaptic membrane | A specialized area of membrane facing the presynaptic membrane on the tip of the nerve ending and separated from it by a minute cleft (the synaptic cleft). Neurotransmitters cross the synaptic cleft and transmit the signal to the postsynaptic membrane. |
presynaptic membrane | A specialized area of membrane of the axon terminal that faces the plasma membrane of the neuron or muscle fiber with which the axon terminal establishes a synaptic junction; many synaptic junctions exhibit structural presynaptic characteristics, such as conical, electron-dense internal protrusions, that distinguish it from the remainder of the axon plasma membrane. |
receptor complex | Any protein complex that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function. |
ruffle membrane | The portion of the plasma membrane surrounding a ruffle. |
semaphorin receptor complex | A stable binary complex of a neurophilin and a plexin, together forming a functional semaphorin receptor. |
15 GO annotations of molecular function
Name | Definition |
---|---|
ATP binding | Binding to ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator. |
coreceptor activity | Combining with an extracellular or intracellular messenger, and in cooperation with a nearby primary receptor, initiating a change in cell activity. |
DNA binding | Any molecular function by which a gene product interacts selectively and non-covalently with DNA (deoxyribonucleic acid). |
ErbB-3 class receptor binding | Binding to the protein-tyrosine kinase receptor ErbB-3/HER3. |
Hsp90 protein binding | Binding to Hsp90 proteins, any of a group of heat shock proteins around 90kDa in size. |
identical protein binding | Binding to an identical protein or proteins. |
protein heterodimerization activity | Binding to a nonidentical protein to form a heterodimer. |
protein tyrosine kinase activity | Catalysis of the reaction |
protein-containing complex binding | Binding to a macromolecular complex. |
receptor tyrosine kinase binding | Binding to a receptor that possesses protein tyrosine kinase activity. |
RNA polymerase I core binding | Binding to a RNA polymerase I core enzyme, a multisubunit eukaryotic nuclear RNA polymerase typically composed of seventeen subunits. |
signaling receptor binding | Binding to one or more specific sites on a receptor molecule, a macromolecule that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function. |
transmembrane receptor protein tyrosine kinase activity | Combining with a signal and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity by catalysis of the reaction |
transmembrane signaling receptor activity | Combining with an extracellular or intracellular signal and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity or state as part of signal transduction. |
ubiquitin protein ligase binding | Binding to a ubiquitin protein ligase enzyme, any of the E3 proteins. |
54 GO annotations of biological process
Name | Definition |
---|---|
cell surface receptor signaling pathway | The series of molecular signals initiated by activation of a receptor on the surface of a cell. The pathway begins with binding of an extracellular ligand to a cell surface receptor, or for receptors that signal in the absence of a ligand, by ligand-withdrawal or the activity of a constitutively active receptor. The pathway ends with regulation of a downstream cellular process, e.g. transcription. |
cellular response to epidermal growth factor stimulus | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an epidermal growth factor stimulus. |
cellular response to growth factor stimulus | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a growth factor stimulus. |
ERBB2-EGFR signaling pathway | The series of molecular signals initiated by binding of a ligand to an epidermal growth factor receptor (EGFR/ERBB1) on the surface of a cell, followed by transmission of the signal by a heterodimeric complex of ERBB2 and EGFR. ERBB2, which does not bind any known ligand, is activated through formation of a heterodimer with another ligand-activated ERBB family member such as EGFR. |
ERBB2-ERBB3 signaling pathway | The series of molecular signals initiated by binding of a ligand to a ERBB3 receptor on the surface of a cell, followed by transmission of the signal by a heterodimeric complex of ERBB2 and ERBB3. ERBB2, which does not bind any known ligand, is activated through formation of a heterodimer with another ligand-activated ERBB family member such as ERBB3. ERBB3 also has impaired kinase activity and relies on ERBB2 for activation and signal transmission. |
ERBB2-ERBB4 signaling pathway | The series of molecular signals initiated by binding of a ligand to a ERBB4 receptor on the surface of a cell, followed by transmission of the signal by a heterodimeric complex of ERBB2 and ERBB4. ERBB2, which does not bind any known ligand, is activated through formation of a heterodimer with another ligand-activated ERBB family member such as ERBB4. |
estrous cycle | A type of ovulation cycle, which occurs in most mammalian therian females, where the endometrium is resorbed if pregnancy does not occur. |
glial cell differentiation | The process in which a relatively unspecialized cell acquires the specialized features of a glial cell. |
heart development | The process whose specific outcome is the progression of the heart over time, from its formation to the mature structure. The heart is a hollow, muscular organ, which, by contracting rhythmically, keeps up the circulation of the blood. |
immature T cell proliferation in thymus | The expansion of an immature T cell population by cell division in the thymus. |
intracellular signal transduction | The process in which a signal is passed on to downstream components within the cell, which become activated themselves to further propagate the signal and finally trigger a change in the function or state of the cell. |
liver development | The process whose specific outcome is the progression of the liver over time, from its formation to the mature structure. The liver is an exocrine gland which secretes bile and functions in metabolism of protein and carbohydrate and fat, synthesizes substances involved in the clotting of the blood, synthesizes vitamin A, detoxifies poisonous substances, stores glycogen, and breaks down worn-out erythrocytes. |
mammary gland involution | The tissue remodeling that removes differentiated mammary epithelia during weaning. |
motor neuron axon guidance | The process in which the migration of an axon growth cone of a motor neuron is directed to a specific target site in response to a combination of attractive and repulsive cues. |
myelination | The process in which myelin sheaths are formed and maintained around neurons. Oligodendrocytes in the brain and spinal cord and Schwann cells in the peripheral nervous system wrap axons with compact layers of their plasma membrane. Adjacent myelin segments are separated by a non-myelinated stretch of axon called a node of Ranvier. |
negative regulation of apoptotic process | Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process. |
negative regulation of immature T cell proliferation in thymus | Any process that stops, prevents, or reduces the frequency, rate or extent of immature T cell proliferation in the thymus. |
nervous system development | The process whose specific outcome is the progression of nervous tissue over time, from its formation to its mature state. |
neurogenesis | Generation of cells within the nervous system. |
neuromuscular junction development | A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of a neuromuscular junction. |
neuron differentiation | The process in which a relatively unspecialized cell acquires specialized features of a neuron. |
neurotransmitter receptor localization to postsynaptic specialization membrane | A process in which a neurotransmitter is transported to, or maintained in, a location within the membrane adjacent to a postsynaptic specialization (e.g. postsynaptic density). |
oligodendrocyte differentiation | The process in which a relatively unspecialized cell acquires the specialized features of an oligodendrocyte. An oligodendrocyte is a type of glial cell involved in myelinating the axons of neurons in the central nervous system. |
peripheral nervous system development | The process whose specific outcome is the progression of the peripheral nervous system over time, from its formation to the mature structure. The peripheral nervous system is one of the two major divisions of the nervous system. Nerves in the PNS connect the central nervous system (CNS) with sensory organs, other organs, muscles, blood vessels and glands. |
phosphatidylinositol 3-kinase/protein kinase B signal transduction | A series of reactions, mediated by the intracellular serine/threonine kinase protein kinase B (also called AKT), which occurs as a result of a single trigger reaction or compound. |
phosphorylation | The process of introducing a phosphate group into a molecule, usually with the formation of a phosphoric ester, a phosphoric anhydride or a phosphoric amide. |
positive regulation of cell adhesion | Any process that activates or increases the frequency, rate or extent of cell adhesion. |
positive regulation of cell growth | Any process that activates or increases the frequency, rate, extent or direction of cell growth. |
positive regulation of cell population proliferation | Any process that activates or increases the rate or extent of cell proliferation. |
positive regulation of epithelial cell proliferation | Any process that activates or increases the rate or extent of epithelial cell proliferation. |
positive regulation of gene expression | Any process that increases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product (protein or RNA). |
positive regulation of MAPK cascade | Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the MAPK cascade. |
positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction | Any process that activates or increases the frequency, rate or extent of protein kinase B signaling, a series of reactions mediated by the intracellular serine/threonine kinase protein kinase B. |
positive regulation of protein phosphorylation | Any process that activates or increases the frequency, rate or extent of addition of phosphate groups to amino acids within a protein. |
positive regulation of protein targeting to membrane | Any process that increases the frequency, rate or extent of the process of directing proteins towards a membrane, usually using signals contained within the protein. |
positive regulation of Ras protein signal transduction | Any process that activates or increases the frequency, rate or extent of Ras protein signal transduction. |
positive regulation of Rho protein signal transduction | Any process that activates or increases the frequency, rate or extent of Rho protein signal transduction. |
positive regulation of transcription by RNA polymerase I | Any process that activates or increases the frequency, rate or extent of transcription mediated by RNA polymerase I. |
positive regulation of translation | Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of proteins by the translation of mRNA or circRNA. |
regulation of cell differentiation | Any process that modulates the frequency, rate or extent of cell differentiation, the process in which relatively unspecialized cells acquire specialized structural and functional features. |
regulation of cell population proliferation | Any process that modulates the frequency, rate or extent of cell proliferation. |
regulation of ERK1 and ERK2 cascade | Any process that modulates the frequency, rate or extent of signal transduction mediated by the ERK1 and ERK2 cascade. |
regulation of microtubule-based process | Any process that modulates the frequency, rate or extent of any cellular process that depends upon or alters the microtubule cytoskeleton. |
response to axon injury | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an axon injury stimulus. |
response to progesterone | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a progesterone stimulus. |
response to xenobiotic stimulus | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus from a xenobiotic, a compound foreign to the organim exposed to it. It may be synthesized by another organism (like ampicilin) or it can be a synthetic chemical. |
Schwann cell development | The process aimed at the progression of a Schwann cell over time, from initial commitment of the cell to a specific fate, to the fully functional differentiated cell. Schwann cells are found in the peripheral nervous system, where they insulate neurons and axons, and regulate the environment in which neurons function. |
semaphorin-plexin signaling pathway | The series of molecular signals generated as a consequence of a semaphorin receptor (composed of a plexin and a neurophilin) binding to a semaphorin ligand. |
signal transduction | The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal (e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light), or for signal transduction in the absence of ligand, signal-withdrawal or the activity of a constitutively active receptor. Signal transduction ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell. |
skeletal muscle tissue development | The developmental sequence of events leading to the formation of adult skeletal muscle tissue. The main events are |
sympathetic nervous system development | The process whose specific outcome is the progression of the sympathetic nervous system over time, from its formation to the mature structure. The sympathetic nervous system is one of the two divisions of the vertebrate autonomic nervous system (the other being the parasympathetic nervous system). The sympathetic preganglionic neurons have their cell bodies in the thoracic and lumbar regions of the spinal cord and connect to the paravertebral chain of sympathetic ganglia. Innervate heart and blood vessels, sweat glands, viscera and the adrenal medulla. Most sympathetic neurons, but not all, use noradrenaline as a post-ganglionic neurotransmitter. |
tongue development | The process whose specific outcome is the progression of the tongue over time, from its formation to the mature structure. The tongue is the movable, muscular organ on the floor of the mouth of most vertebrates, in many other mammals is the principal organ of taste, aids in the prehension of food, in swallowing, and in modifying the voice as in speech. |
transmembrane receptor protein tyrosine kinase signaling pathway | The series of molecular signals initiated by an extracellular ligand binding to a receptor on the surface of the target cell where the receptor possesses tyrosine kinase activity, and ending with the regulation of a downstream cellular process, e.g. transcription. |
wound healing | The series of events that restore integrity to a damaged tissue, following an injury. |
32 homologous proteins in AiPD
UniProt AC | Gene Name | Protein Name | Species | Evidence Code |
---|---|---|---|---|
P13387 | EGFR | Epidermal growth factor receptor | Gallus gallus (Chicken) | SS |
P21860 | ERBB3 | Receptor tyrosine-protein kinase erbB-3 | Homo sapiens (Human) | SS |
P00533 | EGFR | Epidermal growth factor receptor | Homo sapiens (Human) | EV |
Q15303 | ERBB4 | Receptor tyrosine-protein kinase erbB-4 | Homo sapiens (Human) | SS |
P04626 | ERBB2 | Receptor tyrosine-protein kinase erbB-2 | Homo sapiens (Human) | SS |
Q01279 | Egfr | Epidermal growth factor receptor | Mus musculus (Mouse) | SS |
Q61526 | Erbb3 | Receptor tyrosine-protein kinase erbB-3 | Mus musculus (Mouse) | SS |
Q61527 | Erbb4 | Receptor tyrosine-protein kinase erbB-4 | Mus musculus (Mouse) | SS |
P70424 | Erbb2 | Receptor tyrosine-protein kinase erbB-2 | Mus musculus (Mouse) | SS |
Q62799 | Erbb3 | Receptor tyrosine-protein kinase erbB-3 | Rattus norvegicus (Rat) | SS |
Q62956 | Erbb4 | Receptor tyrosine-protein kinase erbB-4 | Rattus norvegicus (Rat) | SS |
G3V9H8 | Ret | Proto-oncogene tyrosine-protein kinase receptor Ret | Rattus norvegicus (Rat) | SS |
Q62838 | Musk | Muscle, skeletal receptor tyrosine protein kinase | Rattus norvegicus (Rat) | SS |
Q63474 | Ddr1 | Epithelial discoidin domain-containing receptor 1 | Rattus norvegicus (Rat) | SS |
Q63604 | Ntrk2 | BDNF/NT-3 growth factors receptor | Rattus norvegicus (Rat) | SS |
P35739 | Ntrk1 | High affinity nerve growth factor receptor | Rattus norvegicus (Rat) | SS |
Q03351 | Ntrk3 | NT-3 growth factor receptor | Rattus norvegicus (Rat) | SS |
Q91ZT1 | Flt4 | Vascular endothelial growth factor receptor 3 | Rattus norvegicus (Rat) | SS |
P53767 | Flt1 | Vascular endothelial growth factor receptor 1 | Rattus norvegicus (Rat) | PR |
O08775 | Kdr | Vascular endothelial growth factor receptor 2 | Rattus norvegicus (Rat) | SS |
Q64716 | Insrr | Insulin receptor-related protein | Rattus norvegicus (Rat) | SS |
P24062 | Igf1r | Insulin-like growth factor 1 receptor | Rattus norvegicus (Rat) | SS |
P15127 | Insr | Insulin receptor | Rattus norvegicus (Rat) | SS |
Q04589 | Fgfr1 | Fibroblast growth factor receptor 1 | Rattus norvegicus (Rat) | SS |
Q498D6 | Fgfr4 | Fibroblast growth factor receptor 4 | Rattus norvegicus (Rat) | PR |
P57097 | Mertk | Tyrosine-protein kinase Mer | Rattus norvegicus (Rat) | SS |
P97523 | Met | Hepatocyte growth factor receptor | Rattus norvegicus (Rat) | PR |
Q05030 | Pdgfrb | Platelet-derived growth factor receptor beta | Rattus norvegicus (Rat) | SS |
P20786 | Pdgfra | Platelet-derived growth factor receptor alpha | Rattus norvegicus (Rat) | SS |
Q00495 | Csf1r | Macrophage colony-stimulating factor 1 receptor | Rattus norvegicus (Rat) | PR |
P55245 | EGFR | Epidermal growth factor receptor | Macaca mulatta (Rhesus macaque) | SS |
O16262 | nipi-4 | Protein nipi-4 | Caenorhabditis elegans | PR |
10 | 20 | 30 | 40 | 50 | 60 |
MELAAWCRWG | FLLALLPPGI | AGTQVCTGTD | MKLRLPASPE | THLDMLRHLY | QGCQVVQGNL |
70 | 80 | 90 | 100 | 110 | 120 |
ELTYVPANAS | LSFLQDIQEV | QGYMLIAHNQ | VKRVPLQRLR | IVRGTQLFED | KYALAVLDNR |
130 | 140 | 150 | 160 | 170 | 180 |
DPQDNVAAST | PGRTPEGLRE | LQLRSLTEIL | KGGVLIRGNP | QLCYQDMVLW | KDVFRKNNQL |
190 | 200 | 210 | 220 | 230 | 240 |
APVDIDTNRS | RACPPCAPAC | KDNHCWGESP | EDCQILTGTI | CTSGCARCKG | RLPTDCCHEQ |
250 | 260 | 270 | 280 | 290 | 300 |
CAAGCTGPKH | SDCLACLHFN | HSGICELHCP | ALVTYNTDTF | ESMHNPEGRY | TFGASCVTTC |
310 | 320 | 330 | 340 | 350 | 360 |
PYNYLSTEVG | SCTLVCPPNN | QEVTAEDGTQ | RCEKCSKPCA | RVCYGLGMEH | LRGARAITSD |
370 | 380 | 390 | 400 | 410 | 420 |
NVQEFDGCKK | IFGSLAFLPE | SFDGDPSSGI | APLRPEQLQV | FETLEEITGY | LYISAWPDSL |
430 | 440 | 450 | 460 | 470 | 480 |
RDLSVFQNLR | IIRGRILHDG | AYSLTLQGLG | IHSLGLRSLR | ELGSGLALIH | RNAHLCFVHT |
490 | 500 | 510 | 520 | 530 | 540 |
VPWDQLFRNP | HQALLHSGNR | PEEDLCVSSG | LVCNSLCAHG | HCWGPGPTQC | VNCSHFLRGQ |
550 | 560 | 570 | 580 | 590 | 600 |
ECVEECRVWK | GLPREYVSDK | RCLPCHPECQ | PQNSSETCFG | SEADQCAACA | HYKDSSSCVA |
610 | 620 | 630 | 640 | 650 | 660 |
RCPSGVKPDL | SYMPIWKYPD | EEGICQPCPI | NCTHSCVDLD | ERGCPAEQRA | SPVTFIIATV |
670 | 680 | 690 | 700 | 710 | 720 |
VGVLLFLILV | VVVGILIKRR | RQKIRKYTMR | RLLQETELVE | PLTPSGAMPN | QAQMRILKET |
730 | 740 | 750 | 760 | 770 | 780 |
ELRKVKVLGS | GAFGTVYKGI | WIPDGENVKI | PVAIKVLREN | TSPKANKEIL | DEAYVMAGVG |
790 | 800 | 810 | 820 | 830 | 840 |
SPYVSRLLGI | CLTSTVQLVT | QLMPYGCLLD | HVREHRGRLG | SQDLLNWCVQ | IAKGMSYLED |
850 | 860 | 870 | 880 | 890 | 900 |
VRLVHRDLAA | RNVLVKSPNH | VKITDFGLAR | LLDIDETEYH | ADGGKVPIKW | MALESILRRR |
910 | 920 | 930 | 940 | 950 | 960 |
FTHQSDVWSY | GVTVWELMTF | GAKPYDGIPA | REIPDLLEKG | ERLPQPPICT | IDVYMIMVKC |
970 | 980 | 990 | 1000 | 1010 | 1020 |
WMIDSECRPR | FRELVSEFSR | MARDPQRFVV | IQNEDLGPSS | PMDSTFYRSL | LEDDDMGDLV |
1030 | 1040 | 1050 | 1060 | 1070 | 1080 |
DAEEYLVPQQ | GFFSPDPTPG | TGSTAHRRHR | SSSTRSGGGE | LTLGLEPSEE | GPPRSPLAPS |
1090 | 1100 | 1110 | 1120 | 1130 | 1140 |
EGAGSDVFDG | DLAMGVTKGL | QSLSPHDLSP | LQRYSEDPTL | PLPPETDGYV | APLACSPQPE |
1150 | 1160 | 1170 | 1180 | 1190 | 1200 |
YVNQSEVQPQ | PPLTPEGPLP | PVRPAGATLE | RPKTLSPGKN | GVVKDVFAFG | GAVENPEYLV |
1210 | 1220 | 1230 | 1240 | 1250 | |
PREGTASPPH | PSPAFSPAFD | NLYYWDQNSS | EQGPPPSNFE | GTPTAENPEY | LGLDVPV |